The U-BIOPRED severe asthma study: Immunopathological characterisation
The U-BIOPRED consortium aims to sub phenotype adult and paediatric patients with severe asthma using an innovative systems medicine approach. The objective of the present study was to characterise the immunopathology in GMA embedded bronchial biopsies. Study included two severe asthma groups, one never smoked and one current/ex-smokers, and a mild-moderate asthma group classified and treated according to the GINA guidelines plus a healthy control group.
The U-BIOPRED consortium will continue to publish findings in the coming months. Sign up to the U-BIOPRED newsletter to keep up to date with U-BIOPRED news and press releases.